Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Shares Drop on European Questions
Motley Fool
Tuesday, January 22, 2013 - 11:36am
tags:
Europe, Arena Pharmaceuticals, Belviq
Vanderbilt fills an R&D void left by Big Pharma cutbacks
Fierce Biotech
Tuesday, January 22, 2013 - 11:35am
tags:
Vanderbilt, R&D
Here's Why Merit Medical Systems's Earnings Are Worse Than They Look
Motley Fool
Tuesday, January 22, 2013 - 11:26am
tags:
earnings, Merit Medical Systems
Device tax: Opponents in Senate look for new avenues for repeal
Mass Device
Tuesday, January 22, 2013 - 11:25am
tags:
device tax, devices
Simcere Pharma sells stake in Shanghai Celgen Bio-Pharmaceutical for about $48 million
Yahoo/AP
Tuesday, January 22, 2013 - 11:23am
tags:
Simcere, Shanghai Celgen Bio-Pharmaceutical
Novartis Scores EU Approval for Meningitis Vaccine
Motley Fool
Tuesday, January 22, 2013 - 11:22am
tags:
Europe, Novartis, vaccines, meningitis, Bexsero
FDA Holds Up Impax Parkinson's Drug Approval Bid
Motley Fool
Tuesday, January 22, 2013 - 11:22am
tags:
FDA, Parkinson's Disease, Impax Labs, Rytary
FDA Declines To Pursue Hearing In Free Speech Case
Pharmalot
Tuesday, January 22, 2013 - 10:48am
tags:
FDA, off-label
Zerenex Phase III Data Imminent; Odds Still High For Keryx To Succeed With This Drug
Seeking Alpha
Tuesday, January 22, 2013 - 10:46am
tags:
Zerenex, Keryx
A.P. Pharma Run-Up Trade Into FDA Approval Decision
TheStreet.com
Tuesday, January 22, 2013 - 10:45am
tags:
AP Pharma, FDA, APF530, chemotherapy-induced nausea and vomiting
SNY's Allerject Launched in Canada
Yahoo/Zacks
Tuesday, January 22, 2013 - 10:44am
tags:
Sanofi, Allerject, Canada, epinephrine auto-injector
Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha
Tuesday, January 22, 2013 - 10:43am
tags:
age-related macular degeneration, Lpath, Merck, Pfizer, Bristol-Myers Squibb, Roche, ShangPharma
Johnson & Johnson Beats Forecast, but 2013 View Lags Expectations
CNBC
Tuesday, January 22, 2013 - 10:41am
tags:
JNJ, earnings
Allergan's Botox Label Expanded
Yahoo/Zacks
Tuesday, January 22, 2013 - 10:40am
tags:
Allergan, Botox, overactive bladder
A Look At 5 Healthcare Giants' Pre-Q4 2012 Earnings Releases
Seeking Alpha
Tuesday, January 22, 2013 - 10:40am
tags:
Intuitive Surgical, Merck, JNJ, Pfizer, Amgen, earnings
Affymax: Investor Darling In 2012 Now Has To Perform In 2013
Seeking Alpha
Monday, January 21, 2013 - 11:42am
tags:
Takeda, Fresenius, Amgen, Affymax
Will Kidney Disease Drug Success Push This Stock Higher?
Motley Fool
Monday, January 21, 2013 - 11:35am
tags:
Keryx, Zerenex, kidney disease
Why Hyperion Is Poised to Pull Back
Motley Fool
Monday, January 21, 2013 - 11:06am
tags:
Hyperion
Never Mind FDA, States Are Crafting Biosimilar Laws
Pharmalot
Monday, January 21, 2013 - 11:04am
tags:
FDA, biosimilars
Bristol-Myers Preview: Will it Miss?
Yahoo/Zacks
Monday, January 21, 2013 - 10:56am
tags:
Bristol-Myers Squibb, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.